Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥446.51 Million ≈ $65.34 Million USD) by net assets (CN¥10.70 Billion ≈ $1.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shijiazhuang Yiling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Shijiazhuang Yiling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Shijiazhuang Yiling Pharmaceutical Co Lt carry for a breakdown of total debt and financial obligations.

Shijiazhuang Yiling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shijiazhuang Yiling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Klabin S.A. SA:KLBN11	0.811x
Sensient Technologies Corporation NYSE:SXT	0.037x
United Breweries Limited NSE:UBL	0.104x
Group 1 Automotive Inc NYSE:GPI	0.046x
Science Applications International Corporation Common Stock NASDAQ:SAIC	0.172x
Dyno Nobel Ltd AU:DNL	0.046x
Trex Company Inc NYSE:TREX	0.189x
Shenzhen Fortune Trend Technology Co Ltd SHG:688318	0.006x

Annual Cash Flow Conversion Efficiency for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥10.20 Billion ≈ $1.49 Billion	CN¥611.01 Million ≈ $89.41 Million	0.060x	+340.66%
2023-12-31	CN¥11.44 Billion ≈ $1.67 Billion	CN¥155.46 Million ≈ $22.75 Million	0.014x	-95.74%
2022-12-31	CN¥10.93 Billion ≈ $1.60 Billion	CN¥3.49 Billion ≈ $510.37 Million	0.319x	+447.54%
2021-12-31	CN¥9.07 Billion ≈ $1.33 Billion	CN¥528.69 Million ≈ $77.36 Million	0.058x	-67.22%
2020-12-31	CN¥8.92 Billion ≈ $1.31 Billion	CN¥1.59 Billion ≈ $232.11 Million	0.178x	+1950.92%
2019-12-31	CN¥7.95 Billion ≈ $1.16 Billion	CN¥68.93 Million ≈ $10.09 Million	0.009x	-9.41%
2018-12-31	CN¥7.56 Billion ≈ $1.11 Billion	CN¥72.37 Million ≈ $10.59 Million	0.010x	-40.65%
2017-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥114.65 Million ≈ $16.78 Million	0.016x	-86.39%
2016-12-31	CN¥5.33 Billion ≈ $780.33 Million	CN¥631.64 Million ≈ $92.43 Million	0.118x	+333.58%
2015-12-31	CN¥4.83 Billion ≈ $706.40 Million	CN¥131.88 Million ≈ $19.30 Million	0.027x	+17.48%
2014-12-31	CN¥4.55 Billion ≈ $666.41 Million	CN¥105.90 Million ≈ $15.50 Million	0.023x	+79.00%
2013-12-31	CN¥4.26 Billion ≈ $623.13 Million	CN¥55.32 Million ≈ $8.10 Million	0.013x	-28.77%
2012-12-31	CN¥3.84 Billion ≈ $562.64 Million	CN¥70.13 Million ≈ $10.26 Million	0.018x	+116.53%
2011-12-31	CN¥3.70 Billion ≈ $541.67 Million	CN¥-408.49 Million ≈ $-59.77 Million	-0.110x	-140.17%
2010-12-31	CN¥1.09 Billion ≈ $159.65 Million	CN¥299.72 Million ≈ $43.86 Million	0.275x	-31.75%
2009-12-31	CN¥790.55 Million ≈ $115.68 Million	CN¥318.21 Million ≈ $46.56 Million	0.403x	-7.30%
2008-12-31	CN¥484.03 Million ≈ $70.83 Million	CN¥210.18 Million ≈ $30.76 Million	0.434x	--

About Shijiazhuang Yiling Pharmaceutical Co Ltd

SHE:002603 China Drug Manufacturers - Specialty & Generic

Market Cap

$4.17 Billion

CN¥28.47 Billion CNY

Market Cap Rank

#4048 Global

#684 in China

Share Price

CN¥17.04

Change (1 day)

+0.41%

52-Week Range

CN¥13.80 - CN¥21.05

All Time High

CN¥1254.44